Discussion
The use of teriparatide, a lab-made version of the parathyroid hormone — low levels of which lead to hypoparathyroidism — should not replace supplement therapy in children with the rare condition, but may benefit young patients who don’t respond well to standard care. That’s the key takeaway from…